登录 | 注册    关注公众号  
微信公众号
搜索
 > 【Fc gamma RIII / CD16】

Fc gamma RIII / CD16信息

英文名称:Low affinity immunoglobulin gamma Fc region receptor III-A
中文名称:低亲和力免疫球蛋白γFc段受体III-A
靶点别称:Fc Fragment Of IgG, Low Affinity IIIa, Receptor (CD16a),CD16a Antigen,IGFR3,FCG3,Fc Fragment Of IgG, Low Affinity IIIa, Receptor For (CD16),Fc Fragment Of IgG, Low Affinity III, Receptor For (CD16),Immunoglobulin G Fc Receptor III,Fc-Gamma Receptor III-2 (CD 16),Neutrophil-Specific Antigen NA,Fc-Gamma Receptor IIIb (CD16),Fc Gamma Receptor III-A,Fc Gamma Receptor IIIa,Fc-Gamma RIIIa,Fc-Gamma RIII,FCGRIII,FcRIIIa,FCR-10,FCRIII,IMD20,CD16,Low affinity immunoglobulin gamma Fc region receptor III-A,
上市药物数量:0
临床药物数量:12
最高研发阶段:临床二期

抗体项目交易平台

项目名称 项目阶段 分子类型 分子来源 疾病领域 适应症

Licensing 项目合作

项目名称 药物类型 治疗领域 适应症 阶段 权益地区

Fc gamma RIII / CD16分子别名

FCGR3

Fc gamma RIII / CD16分子背景

CD16 is a low affinity Fc receptor, and has been identified as Fc receptors FcγRIIIa (CD16a) and FcγRIIIb (CD16b). These receptors bind to the Fc portion of IgG antibodies. CD16 encoded by two different highly homologous genes in a cell type-specific manner.CD16 is found on the surface of natural killer cells, neutrophil polymorphonuclear leukocytes, monocytes and macrophages.
CD16a antigen is also known as Low affinity immunoglobulin gamma Fc region receptor III-A, Fc-gamma RIII-alpha. CD16b is a low-affinity, GPI-linked receptor expressed by neutrophils and eosinophils, whereas CD16a is an intermediate affinity polypeptide-anchored transmembrane glycoprotein expressed natural killer cells, macrophages, subpopulation of T-cells, immature thymocytes and placentaltrophoblasts.CD16a is involved in phagocytosis, secretion of enzymes and inflammatory mediators, antibody­dependent cytotoxicity and clearance of immune complexes. Aberrant expression or mutations of CD16a is implicated in susceptibility to recurrent viral infections, systemic lupus erythematosus, and alloimmune neonatal neutropenia.

Fc gamma RIII / CD16临床药物信息

英文名称 研发代码 研发阶段 公司 适应症 临床试验
FT-538 FT-538 临床二期 Fate Therapeutics Inc 髓样白血病, 卵巢癌, 实体瘤, HIV感染, 新型冠状病毒感染, 肿瘤, 成人呼吸窘迫综合征, 腹膜癌, 急性单核细胞白血病, 急性髓细胞样白血病, 输卵管癌 详情
GMA-161 GMA-161 临床一期 赛诺菲, Macrogenics Inc 特发性血小板减少性紫癜 详情
SAR445514 SAR445514; SAR-445514; IPH6401/SAR'514 临床二期 赛诺菲 淀粉体轻链淀粉样变性, 多发性骨髓瘤 详情
Acimtamig AFM-13 临床二期 德州大学安德森癌症中心 外周T细胞淋巴瘤, 霍奇金病, 间变大细胞淋巴瘤, 非霍奇金淋巴瘤, 蕈样真菌病 详情
FT-516 FT-516 临床一期 University Of Minnesota, Fate Therapeutics Inc B-细胞淋巴瘤, 卵巢癌, 实体瘤, 腹部肿瘤, 新型冠状病毒感染, 急性髓细胞样白血病, 输卵管癌 详情
AFM-28 AFM-28 临床一期 Affimed 急性早幼粒细胞白血病, 肿瘤, 急性髓细胞样白血病 详情
AFM-24 AFM-24 临床二期 Affimed 实体瘤 详情
FT-576 FT-576 临床一期 University Of Minnesota, Fate Therapeutics Inc 骨髓瘤, 多发性骨髓瘤 详情
SM-3321 SM-3321; SM3321 临床一期 北京烁星生物医药科技有限公司 实体瘤, 肿瘤, 急性髓细胞样白血病 详情
FT-596 FT-596 临床一期 Fate Therapeutics Inc B-细胞淋巴瘤, 边缘带B细胞淋巴瘤, 弥漫性大B-细胞淋巴瘤, 滤泡性淋巴瘤, 套细胞淋巴瘤, 急性髓细胞样白血病, 非霍奇金淋巴瘤, 慢性淋巴细胞白血病 详情
SAR-443579 SAR-443579; SAR443579; SAR'579; IPH6101; IPH-6101 临床二期 赛诺菲 血液疾病, 骨髓增生异常综合征, 急性淋巴细胞白血病 详情
IPH-6501 IPH-6501; IPH-65 临床二期 Innate Pharma SA 肿瘤, 非霍奇金淋巴瘤 详情

消息提示

请输入您的联系方式,再点击提交!

确定